Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma (NASDAQ: TBPH) announced its participation in the upcoming BTIG Virtual Biotechnology Conference. The company will engage in a fireside chat on Wednesday, July 30 at 12:00 pm ET (9:00 am PT/5:00 pm IST). Senior management will also be available for one-on-one meetings with investors during the conference.
Interested parties can access the webcast or schedule meetings through their BTIG representative or by emailing [email protected].
Theravance Biopharma (NASDAQ: TBPH) ha annunciato la sua partecipazione alla prossima Conferenza Virtuale di Biotecnologie BTIG. L'azienda prender脿 parte a una conversazione informale mercoled矛 30 luglio alle 12:00 ET (9:00 PT/17:00 IST). Il management senior sar脿 inoltre disponibile per incontri individuali con gli investitori durante la conferenza.
Gli interessati possono accedere alla diretta streaming o fissare appuntamenti tramite il loro rappresentante BTIG o scrivendo a [email protected].
Theravance Biopharma (NASDAQ: TBPH) anunci贸 su participaci贸n en la pr贸xima Conferencia Virtual de Biotecnolog铆a de BTIG. La compa帽铆a participar谩 en una charla informal el mi茅rcoles 30 de julio a las 12:00 pm ET (9:00 am PT/5:00 pm IST). La alta direcci贸n tambi茅n estar谩 disponible para reuniones individuales con inversores durante la conferencia.
Las partes interesadas pueden acceder a la transmisi贸n en vivo o programar reuniones a trav茅s de su representante de BTIG o enviando un correo a [email protected].
Theravance Biopharma (NASDAQ: TBPH)電� 雼り皜鞓る姅 BTIG 臧�靸� 氚旍澊鞓ろ厡韥� 旎嵓霟办姢鞐� 彀胳棳頃� 瓴冹瀯鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 7鞗� 30鞚� 靾橃殧鞚� 霃欕秬鞁滉皠 鞓ろ泟 12鞁�(韮滍弶鞏戩嫓臧� 鞓れ爠 9鞁�/鞚鸽弰 響滌鞁� 鞓ろ泟 5鞁�)鞐� 歆勴枆霅橂姅 雽�雼挫棎 彀胳棳頃� 鞓堨爼鞛呺媹雼�. 瓿犾渼 瓴届榿歆勳潃 旎嵓霟办姢 旮瓣皠 霃欖晥 韴瀽鞛愲摛瓿� 鞚茧寑鞚� 氙疙寘霃� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
甏�鞁� 鞛堧姅 攵勲摛鞚� BTIG 雼措嫻鞛愲ゼ 韱淀暣靹滊倶 [email protected]鞙茧 鞚措⿺鞚检潉 氤措偞 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃橁卑雮� 氙疙寘 鞚检爼鞚� 鞛§潉 靾� 鞛堨姷雼堧嫟.
Theravance Biopharma (NASDAQ : TBPH) a annonc茅 sa participation 脿 la prochaine conf茅rence virtuelle BTIG sur la biotechnologie. La soci茅t茅 participera 脿 une discussion informelle le mercredi 30 juillet 脿 12h00 ET (9h00 PT/17h00 IST). La haute direction sera 茅galement disponible pour des r茅unions individuelles avec les investisseurs pendant la conf茅rence.
Les personnes int茅ress茅es peuvent acc茅der au webcast ou planifier des r茅unions via leur repr茅sentant BTIG ou en envoyant un courriel 脿 [email protected].
Theravance Biopharma (NASDAQ: TBPH) gab seine Teilnahme an der bevorstehenden BTIG Virtual Biotechnology Conference bekannt. Das Unternehmen wird an einem Fireside-Chat am Mittwoch, den 30. Juli um 12:00 Uhr ET (9:00 Uhr PT/17:00 Uhr IST) teilnehmen. Das Senior Management steht w盲hrend der Konferenz auch f眉r Einzelgespr盲che mit Investoren zur Verf眉gung.
Interessierte k枚nnen den Webcast 眉ber ihren BTIG-Vertreter verfolgen oder Meetings vereinbaren, indem sie eine E-Mail an [email protected] senden.
- None.
- None.
About Theravance Biopharma
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference庐 in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI庐 (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA), has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in MSA patients. The Company is committed to creating/driving shareholder value.
For more information, please visit .
THERAVANCE BIOPHARMA庐, THERAVANCE庐 and the Cross/Star logo are registered trademarks of the聽Theravance Biopharma聽group of companies (in the聽U.S.聽and certain other countries).
YUPELRI庐鈥痠s a registered trademark of鈥疺iatris Specialty LLC. Trademarks, trade names or service marks of other companies appearing on this press release are the property of their respective owners.
Contact:
[email protected]
650-808-4045
View original content to download multimedia:
SOURCE Theravance Biopharma, Inc.
FAQ
When is Theravance Biopharma (TBPH) presenting at the BTIG Virtual Biotechnology Conference?
How can investors access Theravance Biopharma's BTIG conference presentation?
Will Theravance Biopharma management be available for meetings at the BTIG conference?
What type of presentation will TBPH give at the BTIG Virtual Biotechnology Conference?
